APA (7th ed.) Citation

Tsubata, Y., Tanino, R., & Isobe, T. (2021). Current Therapeutic Strategies and Prospects for EGFR Mutation-Positive Lung Cancer Based on the Mechanisms Underlying Drug Resistance. MDPI AG.

Chicago Style (17th ed.) Citation

Tsubata, Yukari, Ryosuke Tanino, and Takeshi Isobe. Current Therapeutic Strategies and Prospects for EGFR Mutation-Positive Lung Cancer Based on the Mechanisms Underlying Drug Resistance. MDPI AG, 2021.

MLA (8th ed.) Citation

Tsubata, Yukari, et al. Current Therapeutic Strategies and Prospects for EGFR Mutation-Positive Lung Cancer Based on the Mechanisms Underlying Drug Resistance. MDPI AG, 2021.